MOLN
Molecular Partners AG
There isn't enough reported data to score MOLN yet.
MOLN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
MOLN's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
MOLN PE Valuation
MOLN has no meaningful PE right now: it lost money over the past year.
MOLN Forward outlook
There aren't enough analyst estimates for MOLN to show an outlook.
MOLN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$1.99 | -$0.08 |
| Q2 2025 | -$2.15 | -$0.04 |
| Q4 2024 | -$1.91 | +$0.37 |
| Q2 2024 | -$2.11 | +$0.15 |
| Q4 2023 | -$2.28 | -154% |
| Q4 2022 | $4.26 | +$6.74 |
| Q4 2021 | -$2.48 | +$0.65 |
| Q4 2020 | -$3.13 | -$1.08 |
MOLN is still losing money, but less than at its worst: $1.99 per share over the past year, against $3.13 at its worst in late 2020.
MOLN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $819.8K | -81% |
| Q2 2024 | $5.2M | +24% |
| Q4 2023 | $4.3M | -29% |
| Q2 2023 | $4.2M | -98% |
| Q4 2022 | $6.1M | -48% |
| Q4 2021 | $11.7M | +531% |
| Q4 2020 | $1.9M | -55% |
| Q3 2020 | $340.7K | -92% |
MOLN's revenue has slid since its 2022 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | -4315% | -3729 points |
| Q2 2024 | -742% | -822 points |
| Q4 2023 | -843% | -193 points |
| Q2 2023 | -894% | +405 points |
| Q4 2022 | -586% | +4775 points |
| Q2 2022 | 79% | +372 points |
| Q4 2021 | -650% | -329 points |
| Q4 2020 | -1299% | -944 points |
MOLN's operating margin was −4315% last quarter, down 3729 points from the same quarter a year ago, near the bottom of its range since 2016.
MOLN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$25.6M | +$6.8M |
| Q2 2025 | -$37M | +$2.8M |
| Q4 2024 | -$32.3M | +$3.3M |
| Q2 2024 | -$39.8M | -$3.7M |
| Q4 2023 | -$35.6M | +$4.3M |
| Q2 2023 | -$36.1M | -120% |
| Q4 2022 | -$39.9M | +$70.7M |
| Q4 2021 | -$110.6M | -4638% |
MOLN has burned cash in most quarters: −$135M over the past year, against $70M the year before.
MOLN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +136K shares |
| 1 year | +14% | +4.5M shares |
| 3 years | +72% | +15.6M shares |
| 5 years | +77% | +16.2M shares |
| Available history | +84% | +17M shares |
MOLN has 37M diluted shares, up 14% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
| Q2 2019 | — |
| Q1 2019 | — |
MOLN Net Leverage
MOLN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MOLN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.2 | Neutral |
| Stochastic | 4.6 | Oversold |
MOLN's weekly RSI is 30 (neutral) and its Stochastic is 5 (oversold).
MOLN PE vs Healthcare Sector
| Metric | MOLN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
MOLN has no meaningful PE right now: it lost money over the past year.
MOLN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.64 | 17% below |
| 20 week MA | $3.94 | 24% below |
| 50 week MA | $4.15 | 27% below |
| 100 week MA | $4.15 | 27% below |
| 200 week MA | $4.79 | 37% below |
MOLN is in a downtrend: it's below all five of its weekly moving averages, and 37% below its 200-week average.
MOLN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $19.3 | $20.2 | +4.9% |
| 2022 | $20.2 | $6.55 | -68% |
| 2023 | $6.55 | $4.18 | -36% |
| 2024 | $4.18 | $5.30 | +27% |
| 2025 | $5.30 | $4.23 | -20% |
| 2026 YTD | $4.23 | $3.01 | -29% |
MOLN has finished lower in three of the last five years. It's down 29% so far in 2026.